Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2+ Advanced Breast Cancer × Trastuzumab × Other solid neoplasm × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Breast 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 3 Solid Tumors 2 Solid Tumor 2 Solid Tumor, Adult 1 Relapsed Pediatric Solid Tumor 1 Malignant Solid Neoplasm 1 HER2-positive 1 HER2+ Advanced Breast Cancer 1

Interventions

fludarabine 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06027983 2025-09-23

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

National University Hospital, Singapore

Phase 1/2 Not yet recruiting

BreastOther solid neoplasm

HER2+ Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡